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Background: The relation between pulmonary mycobacteriosis and lung cancer
has been scrutinized for many years but the current evidence is inconsistent as
some studies found an association between the two, whereas others have
reported an insigniﬁcant relation.
Materials and methods: 3224 consecutive patients undergoing elective thoracic
surgery at the Department of Thoracic Surgery of a comprehensive cancer center
over a four-year period were considered. Patients diagnosed with pulmonary
mycobacteriosis with microbiological conﬁrmation on their surgical specimen
were further analyzed.
Results: 30 patients were diagnosed with pulmonary mycobacteriosis: six of them
had a history of cancer. 18 patients received wedge resection, four patients received
anatomic segmentectomy, two were submitted to lobectomy, one underwent
pneumonectomy and ﬁve patients received other types of lesser procedures..e01395
vier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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patients.
Conclusions: Although rare, the incidental diagnoses of pulmonary
mycobacteriosis among patients scheduled for lung cancer resection is not
negligible. Pulmonologists, anesthesiologists and thoracic surgeons should be
aware of this possibility before planning pulmonary resections of histologically
undiagnosed lung nodules.
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1. Introduction
Lung cancer accounts for more than 1.8 million newly diagnosed cancer cases (13%
of the total diagnosed cancer cases) and 1.6 million cancer-related deaths (19.4% of
the total) worldwide every year [1]. It is one of the most frequently diagnosed can-
cers and is the leading global cause of cancer-related death [2].
Tuberculosis (TB) is a mycobacteriosis caused by M. tuberculosis and represents a
global public health problem, remaining one of the major causes of death among in-
fectious diseases. About one third of the human population is estimated to harbor TB
in its latent form [3]. Pulmonary TB represents about 85% of clinical TB cases and as
a chronic inﬂammation process may lead to carcinogenesis of the lung [4].
Currently, more than 125 non-tuberculous mycobacteria (NTM) species have been
cataloged. They may cause both asymptomatic infection and symptomatic illness
in humans, whose most common clinical manifestation is lung disease, although
lymphatic, skin, soft tissue and disseminated disease have also been reported [5].
The probable relation between pulmonary mycobacteriosis and subsequent lung can-
cer development has been scrutinized for many years. However, the current evidence
is inconsistent as some studies found an association between the two, whereas others
have reported an insigniﬁcant relation [6].2. Materials and methods
This is an observational retrospective study. Data were collected prospectively and
entered into our institutional general thoracic database at the point of care and re-
viewed and double-checked retrospectively. Our sample included three thousand
two hundred and twenty-four consecutive patients undergoing elective thoracic sur-
gery for therapeutic or diagnostic purposes at the Department of Thoracic Surgery of
a referral comprehensive cancer center over a four-year period (September
2006eMarch 2010). Among them, patients diagnosed with pulmonary mycobacter-
iosis with microbiological conﬁrmation on their surgical specimen were furtheron.2019.e01395
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and imaging data for scientiﬁc or educational purposes, or both, were obtained from
all patients before surgery.
Age, gender, smoking habits, risk factors for pulmonary tuberculosis and non-
tuberculous mycobacteriosis, type, side and extent of surgical resection, oncologic
history, microbiologic diagnosis and relative antibiograms, bacterioscopic ﬁndings,
pathological ﬁndings, preoperative bronchoscopic results, computed tomography
(CT) and positive emission tomography (PET) ﬁndings, postoperative course, 30-
day or in-hospital morbidity and mortality rates and long-term follow-up data
were collected.
Postoperative death was deﬁned as 30-day mortality or longer if mortality occurred
during hospitalization. Complications were classiﬁed according to the Thoracic
Morbidity and Mortality classiﬁcation system [7] as minor (grades I and II) and ma-
jor (grade IIIa, grade IIIb; grade IVa, grade IVb; grade V).3. Results
Among the 3224 operated patients, 30 were diagnosed with pulmonary mycobacter-
iosis, accounting for 0.9% of the whole study population. They comprised 18 males
(60.0%) and 12 females (40.0%); mean age was 61 13 years; eight patients (26.7%)
were non-smokers, 12 (40.0%) were smokers and ten (33.3%) were former smokers;
six patients (20.0%) presented risk factors related to tuberculous or non-tuberculous
mycobacteriosis: one was human immunodeﬁciency virus (HIV)-positive, three had
autoimmune diseases treated by immunomodulation, while two had chronic obstruc-
tive pulmonary disease (COPD).
Six patients (20.0%) had a history of cancer (3 renal cell carcinomas, 1 Hodgkin lym-
phoma, 1 breast carcinoma and 1 breast carcinoma and endometrial cancer). Preop-
erative bronchoscopy was performed in 19 patients and was positive for
mycobacteriosis in one case and for squamous carcinoma in one case. Preoperative
PET scan was performed in all patients but one and was negative on the target pul-
monary lesion in ﬁve cases (17.2%) and positive in the remaining 24 cases (82.8%).
Mean standardized uptake value was 4.85  5.2; the SUV values on the target le-
sions where cancer was also present were 4.2, 5.4, 10.4 and 24.9. Hilar or medias-
tinal lymph nodes were suspicious in six patients (20.7%). Preoperative CT scan
disclosed solid target lesions in 27 patients (90.0%), cavitated lesions in three
(10.0%) and suspicious lymphoadenomegalies in four (13.3%). Mean major diam-
eter of the lesion was 26 mm (range: 8e61 mm); 5 nodules were located in the
left upper lobe (16.7%); 5 in the left lower lobe (16.7%); 2 in the middle lobe
(6.7%); 3 in the right lower lobe (10.0%); 13 in the right upper lobe (43.2%); in
two patients there were multiple nodules in diﬀerent lobes (6.7%).on.2019.e01395
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resection), four patients (13.3%) received anatomic segmentectomy, two (6.7%)
were submitted to lobectomy, one (3.3%) underwent pneumonectomy and ﬁve pa-
tients (16.7%) received other types of lesser procedures (on the pleura or
lymphnodes).
Mycobacterium tuberculosis was diagnosed by microbiological examination in 13
cases (43.3%), Mycobacterium xenopi in 13 cases (43.3%), Mycobacterium africa-
num in two cases (6.8%), Mycobacterium gordonae in one case (3.3%) and Myco-
bacterium intracellularis in one case (3.3%).
Antibiograms showed the following sensitivity (single or combined): ethambutol in
14 cases, rifabutin in ﬁve cases, rifampicin in 25 cases, streptomycin in 13 cases,
isoniazid in 13 cases, pyrazinamide in 12 cases. No case of multidrug-resistant
mycobacterium was observed. Postoperative bacterioscopic evaluation was positive
in 14 cases (46.7%).
Sputum culture was then routinely performed three times for each patient with sus-
pected mycobacteriosis: it was positive at least once in six patients (20.0%): Myco-
bacterium xenopi was diagnosed in 2 cases; Mycobacterium africanum in 1 case;
Mycobacterium tuberculosis in 3 cases.
In four patients we observed pulmonary mycobacteriosis and synchronous lung can-
cer: squamous carcinoma in two cases, neuroendocrine tumorlets in one case and
poorly diﬀerentiated non-small cell cancer in one case. No oncologic patient
received adjuvant treatments, three because of early stage disease and one because
he died after surgery.
Eight patients (26.7%) presented postoperative complications: three had minor com-
plications and ﬁve (16.7%) had major complications: among them four presented
respiratory failure requiring non-invasive ventilation and one pleural empyema
not requiring redo surgical exploration. The patient who developed respiratory fail-
ure after right pneumonectomy for poorly diﬀerentiated carcinoma died on postop-
erative day 41 from single lung acute respiratory distress syndrome (ARDS)
(postoperative mortality: 3.3%). Mean length of hospital stay was 5  1.7 days.
All patients with a diagnosis of mycobacterium tuberculosis infection received com-
plete therapy except one because of liver toxicity. All patients with a diagnosis of
non-tuberculous mycobacteriosis were successfully treated. No case of recurrence
has been notiﬁed since.
After a mean follow-up of 103  44.1 months, among patients with a diagnosis of
synchronous lung cancer one was alive without any evident disease after 145
months, one was alive with recurrent disease after 16 months, one patient died after
116 months from other causes without any evident disease and one died 41 days afteron.2019.e01395
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ure [Tables 1 and 2].4. Discussion
Although the European region accounts only for 5% of world TB cases, tuberculosis
has re-emerged as a public health concern in high-income countries in the last fewTable 1. Clinico-pathological features of the study population (categorical
variables).
N (%)
Sex Female 18 (60.0)
Male 12 (40.0)
Smoking status Smoker 12 (40.0)
Former smoker 10 (33.3)
Non-smoker 8 (26.7)
Risk factors for TB and NTM (N ¼ 6) HIV 1
Autoimmune diseases 3
COPD 2
History of cancer (N ¼ 6) Renal cell carcinoma 3
Hodgkin lymphoma 1
Breast carcinoma 1
Breast carcinoma þ endometrial cancer 1
Pre-operative PET scan (N ¼ 29) Negative 5 (17.2)
Positive 24 (82.8)
Pre-operative CT scan Solid 27 (90.0)
Cavitated 3 (10.0)
Suspicious lymphoadenomegalies 4 (13.3)
Surgical procedure Wedge resection 18 (60.0)
Anatomic segmentectomy 4 (13.3)
Lobectomy 2 (6.7)
Pneumonectomy 1 (3.3)
Other 5 (16.7)
Mycobacteria M. Tuberculosis 13 (43.3)
M. Xenopi 13 (43.3)
M. Africanum 2 (6.8)
M. Gordonae 1 (3.3)
M. Intracellulare 1 (3.3)
Postoperative complications Overall 8 (26.6)
Major 3 (10.0)
Minor 5 (16.6)
on.2019.e01395
by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Table 2. Clinico-pathological features of the study population (continuous
variables).
N Mean ± SDx min,max
Age at Surgery, years 30 61  13 26,77
Mean standardized uptake value, SUV 29 4.85  5.2 0.6,24.9
Length of stay, days 30 5  1.7 3,41
xSD: Standard Deviation.
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observed in lung cancer patients, diﬀerential diagnosis can be diﬃcult, particularly
when lung cancer and pulmonary mycobacteriosis coexist in the same mass or in
diﬀerent anatomical structures (lung, lymph node or pleura) in the same patient.
Moreover, lung cancer and pulmonary mycobacteriosis often share the same symp-
toms such as fever, cough, expectoration, hemoptysis, weight loss and anorexia [9,
10].
Although the incidence of TB in Italy has remained constant at under 10 cases/
100,000 inhabitants - the threshold considered to deﬁne a country as low prevalence
- the incidence rate is 3.8 cases per 100,000 for people born in Italy and 50e60 cases
per 100,000 for those born abroad [11]. Hence it can be argued that even in European
high-income countries the frequency of pulmonary mycobacteriosis is not anecdotal,
and given the high incidence of lung cancer in industrialized countries, the coexis-
tence of both diseases may represent a diagnostic and therapeutic challenge.
Mycobacteriosis e in particular tuberculosis e and lung cancer share similar risk
factors, like smoking. The reduced clearance of airway secretions and impaired ac-
tivity of alveolar macrophages observed in smoker patients contribute to M. tuber-
culosis escaping from the host’s ﬁrst line of defence [12]. On the other hand, the
causal relation between smoking and lung cancer has been historically well proven.
Although eight patients in our series were never smokers, the vast majority were
active or former smokers and only among these patients was the coexistence of
lung cancer and mycobacteriosis diagnosed.
Our CT ﬁndings disclosed solid lesions in 90.0% of patients, thus conﬁrming that
pulmonary mycobacteriosis is almost identical to lung cancer. Similarly, SUV values
of mycobacteriosis were the same as those of neoplastic lesions. Although in our
experience patients presenting with concomitant diseases (mycobacteriosis and
lung cancer) presented higher SUV values, no clear cut-oﬀ was identiﬁed to discrim-
inate between neoplastic and infective lesions.
In our series diagnostic bronchoscopy was performed in 19 out of 30 patients with
tuberculous infection detected preoperatively only in one case: this aspect merits
several methodological and clinical considerations. Firstly, all patients were referredon.2019.e01395
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cer. Therefore ﬂexible bronchoscopy was planned whenever the lesion was attain-
able by endoscopic approach, whereas very peripheral lesions were submitted to
transthoracic CT-guided pulmonary biopsy for histologic characterization. In
some cases of small highly suspicious lesions, the preoperative diagnostic approach
was skipped and surgery performed for diagnostic purposes. The study was conduct-
ed in a low TB prevalence country, in particular on patients born in Italy whose TB
incidence rate is 3.8 per 100,000, thus making our ﬁnal ﬁndings almost unexpected.
During the study period acid fast bacilli (AFB) culture using bronchial washing ﬂuid
(BAL) was not routinely performed, although non tuberculous mycobacteriosis
could be eﬀectively diagnosed by bronchoscopy [13]. On the basis of these results,
an acid-fast bacilli smear and mycobacterial culture is now always performed on
samples of bronchial secretions in case of potential TB lesions. This will identify pa-
tients as smear-positive pulmonary TB and smear-negative pulmonary TB, accord-
ing to World Health Organization criteria [14]. Due to the same reasons, we did not
routinely performed serologic investigation for mycobacteriosis, being this a limit of
the present study.
In conclusion, although rare, the incidental diagnoses of pulmonary mycobacteriosis
among patients scheduled for lung cancer resection is not negligible. Considering the
increasing trend of these infections in industrialized countries, pulmonologists, an-
esthesiologists and thoracic surgeons should be always aware of this possibility
before planning pulmonary resections of non-histologically characterized lung
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